Expression and clinical significance of CD40 protein in human bladder cancer tissue
10.3760/cma.j.issn.1006-9801.2010.04.002
- VernacularTitle:CD40蛋白质在膀胱尿路上皮癌组织中的表达及其临床意义
- Author:
Ning YANG
;
Zhigang LUO
- Publication Type:Journal Article
- Keywords:
Bladder urothelium cancer;
CD40 protein;
Apoptosis
- From:
Cancer Research and Clinic
2010;22(4):219-221
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the expression of CD40 protein in bladder urothelium cancer and to explore its correlation with clinical stage, pathological grades, cell apoptosis. Methods Expression of CD4o protein was evaluated by immunohistochemistry in paracancerous tissues (20 cases) and bladder urothelium cancer tissues (78 cases). Apoptosis of bladder urothelium cancer tissues was detected by Hoechst to determine the apoptotic rate (AR). Results The expression rate of CD40 protein was 2/20(10 %) in the cases of paracancerous tissues, 55/78(70.5%) in the cases of bladder urothelium cancer tissues, a statistically significant differences of CD40 staining was observed between paracancerous tissues and bladder urothelium cancer tissues (P ＜0.01). Overexpression of CD40 was strongly inversely related to the tumor grade and clinical stage; the positive group of CD40 protein was (12.60±0.38)%, the negative group of CD40 protein was (6.77±0.53)%, a statistically significant differences of apoptosis were observed between CD40 protein positive group and CD40 protein negative group (P ＜0.01). It showed CD40 protein might induce cell apoptosis. Conclusion Expression of CD40 protein is closely related with clinical stage, pathological grade and cell apoptotic rate and may offer reliable evidence for diagnosis, treatment and prognosis in bladder urothelium cancer.
